Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -0.66% | 245.10 | 1.5% | $887.83m | |
| MRNA | Moderna, Inc. | 0.73% | 156.67 | 0.0% | $858.81m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.93% | 291.67 | 1.9% | $513.59m | |
| GILD | Gilead Sciences, Inc. | -0.18% | 62.23 | 1.0% | $476.46m | |
| NVAX | Novavax, Inc. | -2.48% | 62.70 | 75.7% | $457.30m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.87% | 591.36 | 2.6% | $448.85m | |
| ILMN | Illumina, Inc. | 1.22% | 195.37 | 3.3% | $361.99m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.53% | 3.80 | 0.7% | $265.63m | |
| BIIB | Biogen, Inc. | 0.93% | 214.57 | 1.8% | $247.46m | |
| BNTX | BioNTech SE | -1.71% | 158.28 | 0.0% | $212.28m | |
| CRSP | CRISPR Therapeutics AG | 0.94% | 71.27 | 0.6% | $194.34m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.12% | 86.26 | 4.2% | $117.34m | |
| AXSM | Axsome Therapeutics, Inc. | 2.70% | 42.32 | 1.8% | $102.01m | |
| EXAS | EXACT Sciences Corp. | -1.64% | 43.67 | 17.7% | $100.83m | |
| TECH | Bio-Techne Corp. | -0.15% | 361.75 | 4.5% | $95.97m |
Company Profile
Ikena Oncology, Inc. is a clinical stage biotechnology company. It discovers and develops patient directed, biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412 and IK-007. The company was founded by Mark Manfredi and George Georgiou in February 2016 and is headquartered in Boston, MA.